If you didn't find what you were looking for, try a new search!
CeQur Appoints Rick Doubleday and Dr Meret Gaugler to Board of Directors Accomplished executives with decades of healthcare experience join board as CeQur Simplicity™ advances toward commercialization LUCERNE, Switzerland & MARLBOROUGH, Mass.— (BUSINESS WIRE) — CeQur®, a medical device company committed [...]
CeQur Raises $115 Million Series C5 Financing Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led by Credit Suisse [...]
Interview with Bradley Paddock, CEO of CeQur In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its [...]
CeQur appoints Bradley Paddock Chief Executive Officer Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. [...]
CeQur acquires J&J’s Calibra Finesse (OneTouch Via) bolus patch device US launch expected in mid-2019 – July 17, 2018 In a major positive for CeQur, the European insulin delivery start-up has acquired Calibra Finesse (One Touch Via) from J&J, the [...]
CeQur SA names Robert O’Holla EVP for Regulatory Affairs Former Worldwide VP for Regulatory Affairs at Johnson & Johnson Brings Vast Experience in Medical Device Submissions, Approvals and GMP Compliance. MONTREUX, Switzerland, April 13, 2010 – CeQur SA, a company [...]